29 C
Vientiane
Friday, April 18, 2025
spot_img

Cision PR Newswire

Akeso’s Ebdarokimab ( IL – 12/IL – 23 Dual – Targeted Monoclonal Antibody) Approved in China for Moderate – to – Severe Plaque Psoriasis

HONG KONG, April 18, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that ebdarokimab, an investigational monoclonal antibody developed by the company, has received marketing approval from the National Medical Products Administration (NMPA) for the treatment of moderate-to-severe plaque psoriasis in adult patients....

Heaven747 Songkran Festival 2025 Marks the Start of a New Era for New Poipet, Cambodia

POIPET, Cambodia, April 18, 2025 /PRNewswire/ -- The highly anticipated Heaven747 Songkran Festival 2025 made...

Squirrel Ai Co-Founder Joleen Liang Highlights the Role of AI in Critical Thinking at ASU+GSV Summit

SHANGHAI, April 18, 2025 /PRNewswire/ -- The ASU+GSV Summit, co-hosted by Arizona State University (ASU)...

So-Young International Inc. Files Its Annual Report on Form 20-F

BEIJING, April 18, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the...

2025 CAA Report & 97th Anniversary Academic Series Overview

Creating Art of the Era, Shaping a New Global Art Landscape HANGZHOU, China,...

The 2025 TTV SUPER STAR Concludes Successfully

Popular Japanese Boy Band King & Prince Delivers a Captivating Overseas Performance TAIPEI, Feb. 4, 2025 /PRNewswire/ -- The 2025 TTV SUPER STAR, which...

Sojern Unveils its 2025 State of Destination Marketing Report

SAN FRANCISCO, Feb. 4, 2025 /PRNewswire/ -- Sojern, the leading digital marketing platform built for travel, is excited to announce the launch of the "State...